Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascepa on Endothelial Function in Type 2 Diabetes
NCT02422446Phase 3Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2015
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in hypertriglyceridemia, type 2 diabetes mellitus (T2DM), sponsored by Brigham and Women's Hospital. Started Apr 2015; status: terminated.
02
Drugs
omega-3-acid triglycerides
03
Conditions
hypertriglyceridemiatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02422446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02422446.